VP Clinical Operations,
Genuity Science (Ireland) Ltd.
David leads Genuity Science’s global clinical operations and programmes and is the managing director of our Ireland site. David is primarily responsible for the establishment and management of long-term research partnerships with world leading health systems, biobanks and cohort research groups. The work of David and his team supports the ethical and responsible sourcing of human biological samples and deep phenotype data, the downstream project management of related genomic analysis projects and the support of the ongoing needs of our academic and healthcare partners. The team’s efforts ensure that our research teams have access to the highest quality data in order to deliver breakthrough insights to our pharma and biotech customers.
David has extensive experience in life sciences and has held leadership roles in several high-growth academic and commercial life science organisations including Systems Biology Ireland, located at University College Dublin and CompareNetworks, a San Francisco-based life science marketing company. David’s areas of specialty include life science innovation and commercialisation, operational & high performing team development in life science start-up environments, genomics, systems biology, connected health, life science text mining and healthcare consulting.
David holds a PhD in Biochemistry from University College Dublin.
Senior Investment Manager – Life Sciences, Ireland Strategic Investment Fund
Georgina is a Senior Investment Manager, specialising in Life Science investment for the Ireland Strategic Investment Fund (ISIF). Georgina joined the ISIF in 2018. She has extensive experience in life science investment and technology commercialisation, having led licencing and co-development deals as well as spin-out company creation programs for over 13 years, both in Ireland and in the US. As Senior Licensing Manager, at Mass General Brigham, Georgina was responsible for the management and licensing of intellectual property arising from neuroscience research at the Brigham and Women’s Hospital, Massachusetts General Hospital and McLean Hospital. Prior to joining the ISIF, Georgina led life science investment for the University Bridge Fund at Atlantic Bridge, investing in early-stage companies leveraging world-class research from Irish third-level institutions and universities.
Georgina holds hold a BSc in Pharmacology, a PhD in Neuropharmacology and a Diploma in Intellectual Property and Technology Law.
SVP, Finance, Genuity Science
Colin joined Genuity Science in 2015 overseeing all aspects of finance and administration for the Irish entity (Genomics Medicine Ireland Ltd.). He played a major role in building GMI from its inception including the integration and restructure of GMI into Genuity Science, and is a key business leader in the organisation.
Prior to joining the company, Colin worked in senior financial positions in global manufacturing companies, initially in the UK and other parts of Europe. In Ireland, he has worked for a number of companies, helping them to solve issues, create value, maximise growth and improve business performance. His experience crosses many multi-functional areas and has been applied to the rapid scaling of Genuity Science.
Colin is a Qualified Accountant and Treasurer, and he received his Economics and Law degree from Durham University, England.